CUSIP: 23283K105
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,416,341
-
Share change
-
-2,599,541
-
Total reported value
-
$8,514,177
-
Price per share
-
$0.49
-
Number of holders
-
70
-
Value change
-
-$1,407,839
-
Number of buys
-
27
-
Number of sells
-
33
Quarterly Holders Quick Answers
What is CUSIP 23283K105?
CUSIP 23283K105 identifies CYTX - CYTORI THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 23283K105:
Institutional Holders of CYTORI THERAPEUTICS INC - COM (CYTX) as of Q4 2014
As of 31 Dec 2014,
CYTORI THERAPEUTICS INC - COM (CYTX) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,416,341 shares.
The largest 10 holders included
BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, State Street Corp, NORTHERN TRUST CORP, PERKINS CAPITAL MANAGEMENT INC, GOLDMAN CAPITAL MANAGEMENT INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.